LIFECORE BIOMEDICAL, INC. Adjustments to Additional Paid in Capital, Other
LIFECORE BIOMEDICAL, INC. (LFCR) reported Adjustments to Additional Paid in Capital, Other of -$75.00 thousand for the 3-month period ending 2019-11-24, per its 10-Q filed 2020-01-02.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-01-02
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, other for the quarter ending 2019-11-24 was -$75.00K.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, other for the quarter ending 2019-08-25 was -$55.00K.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, other for the quarter ending 2019-02-24 was -$95.00K.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, other for the quarter ending 2018-11-25 was -$237.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month |
|---|---|---|---|
| 2019-11-24 | -$75.00K 10-Q · filed 2020-01-02 | -$130.00K derived: sum of 2 quarters · filed 2020-01-02 | |
| 2019-08-25 | -$55.00K 10-Q · filed 2020-01-02 | ||
| 2019-02-24 | -$95.00K 10-Q · filed 2019-04-04 | -$332.00K derived: sum of 2 quarters · filed 2020-01-02 | -$342.00K derived: sum of 3 quarters · filed 2020-01-02 |
| 2018-11-25 | -$237.00K 10-Q · filed 2020-01-02 | -$247.00K 10-Q · filed 2019-01-07 | |
| 2018-08-26 | -$10.00K 10-Q · filed 2020-01-02 | ||
| 2017-11-26 | -$213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$256.00K 10-Q · filed 2018-01-05 | |
| 2017-08-27 | -$43.00K 10-Q · filed 2017-09-28 | ||
| 2017-02-26 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | -$385.00K 10-Q · filed 2017-04-07 | |
| 2016-11-27 | -$272.00K 10-Q · filed 2017-01-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |